跳至主要内容
临床试验/JPRN-UMIN000035031
JPRN-UMIN000035031已完成未知

Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Anticonvulsants in Japan - Risk of SJS/TEN Associated with Anticonvulsants in Japan

Division of Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University0 个研究点目标入组 355 人开始时间: 2018年11月27日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
355

研究概览

简要总结

There were increased odds of SJS/TEN in the new users of carbamazepine (OR 68.00, 95% confidence interval [CI] 8.49 to 8792.29) and lamotrigine (OR 36.00, 95% CI 3.84 to 4770.48). The ALDEN score was more than probable for 100% of cases exposed to lamotrigine or carbamazepine. The 90-day cumulative incidences of SJS/TEN per 100,000 new users were 93.83 for carbamazepine and 84.33 for lamotrigine. We found no significant elevated odds in the users of other anticonvulsants.

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Cohort study: None Matched case-control study: Patients who did not have an observational period of >180 days prior to the index date

研究者

发起方
Division of Drug Development and Regulatory Science, Faculty of Pharmacy, Keio University

相似试验